Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FBPZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,365
Award facts
- Contract value 100% obligated
- $12,364.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on December 22, 2025, with an ultimate completion date of December 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this firm fixed-price delivery order with no set-aside designation. The award represents a routine pharmaceutical supply transaction under DLA's Medical Supply Chain division operations, which procures critical medications for Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative awarded on November 13, 2025. The underlying PPV-G GEN V program, valued at $30.3 billion government-wide, establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support military medical operations globally. DMS Pharmaceutical Group's IDC carries a $499.99 billion ceiling value and extends through December 31, 2036, positioning the company as a critical supplier for DoD healthcare requirements across the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBPZG?
SPE2DR26FBPZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FBPZG worth?
The government has obligated $12,365 on SPE2DR26FBPZG.
Is contract SPE2DR26FBPZG an order under another contract?
Yes. SPE2DR26FBPZG is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBPZG competed?
The extent of competition for SPE2DR26FBPZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award